Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Kiichiro Ninomiya, Isao Oze, Yuka Kato, Toshio Kubo, Eiki Ichihara, Kammei Rai, Kadoaki Ohashi, Toshiyuki Kozuki, Masahiro Tabata, Yoshinobu Maeda, Katsuyuki Kiura & Katsuyuki Hotta. (2020) Influence of age on the efficacy of immune checkpoint inhibitors in advanced cancers: a systematic review and meta-analysis. Acta Oncologica 59:3, pages 249-256.
Read now
Read now
Katsuyuki Hotta, Nobukazu Fujimoto, Toshiyuki Kozuki, Keisuke Aoe & Katsuyuki Kiura. (2020) Nivolumab for the treatment of unresectable pleural mesothelioma. Expert Opinion on Biological Therapy 20:2, pages 109-114.
Read now
Read now
Articles from other publishers (14)
Yanshuo Cao, Ming Lu, Yu Sun, Jifang Gong, Jie Li, Zhihao Lu, Jian Li, Xiaotian Zhang, Yan Li, Zhi Peng, Jun Zhou, Xicheng Wang & Lin Shen. (2022) Surufatinib plus toripalimab in patients with advanced solid tumors: a single-arm, open-label, phase 1 trial. Journal of Cancer Research and Clinical Oncology 149:2, pages 779-789.
Crossref
Crossref
Li Jiang, Jing Zhang, Haimin Xu, Huifang Liu, Chaofu Wang & Xiaoyan Chen. (2023) Comparison of 22C3-PD-L1 Expression Between Paired Tumor Paraffin Blocks of Surgical Resection Specimens of Nonsmall Cell Lung Cancer. Applied Immunohistochemistry & Molecular Morphology 31:1, pages 33-39.
Crossref
Crossref
Jennifer S Lees, Benjamin M P Elyan, Sandra M Herrmann, Ninian N Lang, Robert J Jones & Patrick B Mark. (2022) The ‘other’ big complication: how chronic kidney disease impacts on cancer risks and outcomes. Nephrology Dialysis Transplantation.
Crossref
Crossref
Wen-Jing Yang, Lin Shi, Xiao-Min Wang & Guo-Wang Yang. (2021) Heparanase is a novel biomarker for immune infiltration and prognosis in breast cancer. Aging 13:16, pages 20836-20852.
Crossref
Crossref
Runbo Zhong, Yunbin Zhang, Dongfang Chen, Shuhui Cao, Baohui Han & Hua Zhong. (2021) Single-cell RNA sequencing reveals cellular and molecular immune profile in a Pembrolizumab-responsive PD-L1-negative lung cancer patient. Cancer Immunology, Immunotherapy 70:8, pages 2261-2274.
Crossref
Crossref
Rui Guan, Qiong Lyu, Anqi Lin, Junyi Liang, Weimin Ding, Manming Cao, Peng Luo & Jian Zhang. (2021) Influence of Different Age Cutoff Points on the Prediction of Prognosis of Cancer Patients Receiving ICIs and Potential Mechanistic Exploration. Frontiers in Oncology 11.
Crossref
Crossref
Yehuda Galili, Ahmad El-Far, Jennifer Tseng & Steve Carlan. (2021) Role of immunotherapy in oligometastatic nonsmall cell lung cancer. BMJ Case Reports 14:5, pages e241070.
Crossref
Crossref
Chunlan Wu, Li Zhong, Qing Wu, Shaowei Lin & Xianhe Xie. (2021) The safety and efficacy of immune-checkpoint inhibitors in patients with cancer and pre-existing autoimmune diseases. Immunotherapy 13:6, pages 527-539.
Crossref
Crossref
Yuli Jian, Kangkang Yang, Xiaoxin Sun, Jun Zhao, Kai Huang, Abdullah Aldanakh, Zhongyang Xu, Haotian Wu, Qiwei Xu, Lin Zhang, Chunyan Xu, Deyong Yang & Shujing Wang. (2021) Current Advance of Immune Evasion Mechanisms and Emerging Immunotherapies in Renal Cell Carcinoma. Frontiers in Immunology 12.
Crossref
Crossref
Zhenxin Wang, Guoqing Zhang, Zhongcheng Li, Jin Li, Hongbo Ma, Ailian Hei, Shunchang Jiao, Yi Hu, Shengjie Sun, Liangliang Wu, Ji Zhou, Yu Wang, Ellen He & Sven Skog. (2021) STK1p as a prognostic biomarker for overall survival in non-small-cell lung carcinoma, based on real-world data. Future Science OA 7:3.
Crossref
Crossref
Haiping Jiang, Yulong Zheng, Jiong Qian, Chenyu Mao, Xin Xu, Ning Li, Cheng Xiao, Huan Wang, Lisong Teng, Hui Zhou, Shuyan Wang, Donglei Zhu, Tao Sun, Yingying Yu, Wenying Guo & Nong Xu. (2020) Efficacy and safety of sintilimab in combination with chemotherapy in previously untreated advanced or metastatic nonsquamous or squamous NSCLC: two cohorts of an open-label, phase 1b study. Cancer Immunology, Immunotherapy 70:3, pages 857-868.
Crossref
Crossref
Go Makimoto, Katsuyuki Hotta & Katsuyuki Kiura. (2019) Recent trends in the treatment of unresectable stage III non-small-cell lung cancer. Respiratory Investigation 57:4, pages 330-336.
Crossref
Crossref
Stefania Crisci, Raffaele Di Francia, Sara Mele, Pasquale Vitale, Giuseppina Ronga, Rosaria De Filippi, Massimiliano Berretta, Paola Rossi & Antonio Pinto. (2019) Overview of Targeted Drugs for Mature B-Cell Non-hodgkin Lymphomas. Frontiers in Oncology 9.
Crossref
Crossref
Polyxeni Ntontsi, Clementine Bostantzoglou & Torsten Gerriet Blum. (2019) Highlights of thoracic oncology from the 2018 ERS International Congress. ERJ Open Research 5:2, pages 00222-2018.
Crossref
Crossref